Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Mineralys Therapeutics granted inducement equity awards to two new non-executive employees under Nasdaq Listing Rule 5635(c)(4). The awards include options covering 29,760 shares and restricted stock units covering 22,320 shares, both vesting over four years.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.